Genome-wide association studies burst onto the scene in the mid-2000s, and they are showing their worth for predicting disease risk, classifying disease, and examining gene-drug interactions, writes Muin Khoury, the director of the public health genomics office at the US Centers for Disease Control and Prevention, at the Genomics and Health Impact Blog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.